• Improving
    Outcomes in
    Solid Tumor
    Cancer Treatment

    BIO300
    A New Class of Cancer Drug.
    Kills Cancer Cells.  Protects Normal Tissue.

  • Keeping America Safe

    BIO300
    Protecting Civilians, First Responders and Our Military
    from Nuclear Accidents and Terrorism.

Humanetics News

09.12.17

Humanetics Receives Patent for Cancer Drug

Read more

08.22.17

Humanetics to Present at Department of Defense Scientific Meeting

Read more

01.24.17

Humanetics Awarded Patent to Mitigate Erectile Dysfunction Associated with Prostate Cancer Radiotherapy

Read more

08.10.16

Humanetics Receives $597,000 Federal Grant to Continue Development of BIO 300 as a Medical Radiation Countermeasure

Read more

05.17.16

National Space Biology Research Institute to Fund Testing of BIO 300 to Protect Astronauts from Space Radiation
Read More

06.02.15

Humanetics Corporation Granted FDA Clearance To Proceed With Cancer Treatment Study
Read More

02.12.15

Humanetics Corportation Developing Compound That Could Protect Against Damage Caused by CT Scans and X-Rays
Read More

07.09.14

New Grant Enables Humanetics Corporation to Evaluate Potential Treatment for Erectile Dysfunction in Prostate Cancer Patients
Read More

02.25.14

Humanetics Corporation Enters Into Cooperative Research and Developement Agreement with the U.S. Army Medical Research Institute of Chemical Defense
Read More